INTEGRATED PROTEINS LTD.

Integrated Proteins Limited has incorporated a wholly owned subsidiary, TERRANEXA AGTECH INC, in New Jersey, USA. The subsidiary has an authorized and paid-up share capital of $1,000 USD (approximately ₹95,000). Its primary object is to engage in agricultural technology services and other lawful activities. This move is intended to leverage new growth opportunities in the US markets. The incorporation required approvals from the Reserve Bank of India and US regulatory authorities. The cost of acquisition per share is at face value of $1.

Integrated Proteins Limited held its Annual General Meeting (AGM) on September 30, 2026, conducted via Video Conferencing (VC)/Other Audio-Visual Means (OAVM). Key resolutions passed included the adoption of financial statements, regularization of Mr. Sandeep Mahadik's appointment as Independent Director, and the appointment of Ms. Ankita Shah as the Secretarial Auditor. Ms. Ankita Shah also served as the Scrutinizer for the e-voting process. The AGM commenced at 13:00 IST and concluded at 13:22 IST. Voting results are to be communicated to BSE within two working days.

Integrated Proteins Ltd announced the appointment of Mr. Sandeep Mahadik as an Independent Director during its Annual General Meeting (AGM) held on September 30, 2026. The AGM was conducted via Video Conferencing (VC)/Other Audio-Visual Means (OAVM). The appointment was one of four resolutions presented to the members for approval, alongside the adoption of financial statements, appointment of a Secretarial Auditor, and regularization of Mr. Mahadik's directorship. Voting results for these resolutions will be communicated to BSE Limited within two working days and published on the company's website.

Integrated Proteins Limited held its Annual General Meeting (AGM) on September 30, 2026, conducted via Video Conferencing. During the AGM, the appointment of Ms. Ankita Shah, Practicing Company Secretary, as the Secretarial Auditor for the financial year 2026-27 was approved by the members. The meeting also covered the adoption of financial statements and the regularization of Mr. Sandeep Mahadik's appointment as an Independent Director. Ms. Ankita Shah also served as the Scrutinizer for the e-voting process. The voting results are to be communicated to BSE within two working days.

Integrated Proteins Ltd announced the appointment of Mr. Sandeep Mahadik as an Independent Director during its Annual General Meeting (AGM) held on September 30, 2026. The appointment was regularized through a resolution passed at the AGM, conducted via Video Conferencing (VC)/Other Audio-Visual Means (OAVM). The meeting also saw the adoption of financial statements and the appointment of Ms. Ankita Shah as Secretarial Auditor. Voting results for all resolutions will be communicated to BSE Limited within two working days.

Integrated Proteins Ltd has announced the closure of its trading window from October 1st, 2026, until 48 hours after the conclusion of its upcoming Board Meeting. This meeting is scheduled to consider and approve the Unaudited Financial Results for the quarter ending September 30th, 2026. During this period, promoters, directors, key managerial personnel, designated persons, employees, and their immediate relatives are prohibited from trading in the company's securities. The exact date of the Board Meeting will be communicated separately.

Integrated Proteins Ltd has announced its 33rd Annual General Meeting (AGM) to be held on September 30, 2026, via Video Conferencing. The agenda includes the adoption of the financial statements for the fiscal year 2025-26, along with the Board of Directors' and Auditors' reports. Key special business items include the regularization of Mr. Sandeep Mahadik's appointment as an Independent Director for a five-year term and the appointment of Ms. Ankita Shah as the Secretarial Auditor.

Integrated Proteins Limited has informed the stock exchange about the assignment of a new ISIN, INE177M01021, following the sub-division/split of its equity shares. This corporate action, approved by shareholders on August 20, 2026, and effective from September 4, 2026, reduces the face value of each equity share to Rs. 1/-. The new ISIN has been activated in the NSDL and CDSL systems, with the company providing activation letters as proof. This change is in compliance with SEBI's Listing Regulations.

Integrated Proteins Limited has announced Friday, September 4, 2026, as the record date for its equity share sub-division. The company's members approved the split of equity shares with a face value of ₹10 each into 10 equity shares of ₹1 each at an Extra Ordinary General Meeting held on August 20, 2026. This corporate action aims to increase the liquidity and affordability of the company's shares.

Integrated Proteins Ltd announced that its Board of Directors has considered and approved the unaudited financial results for the quarter ended June 30, 2026. The results were presented along with a limited review report from the auditors. The board meeting took place on August 14, 2026, from 13:00 to 15:50 IST. The company reported a revenue from operations of ₹1,054.73 Lakhs for the quarter, with a profit after tax of ₹36.26 Lakhs. This filing complies with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.